Ad is loading...
GCITX
Price
$14.05
Change
-$0.09 (-0.64%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GCITX vs VTSNX

Header iconGCITX vs VTSNX Comparison
Open Charts GCITX vs VTSNXBanner chart's image
Goldman Sachs Intl Eq Insghts I
Price$14.05
Change-$0.09 (-0.64%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GCITX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCITX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCITX is a StrongSell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GCITX (1.77B). VTSNX pays higher dividends than GCITX: VTSNX (3.29) vs GCITX (2.62). GCITX was incepted earlier than VTSNX: GCITX (17 years) vs VTSNX (14 years). GCITX is a more actively managed with annual turnover of: 157.00 vs. VTSNX (4.00). GCITX has a lower initial minimum investment than VTSNX: GCITX (0) vs VTSNX (5000000). GCITX annual gain was more profitable for investors over the last year : 14.36 vs. VTSNX (10.92). GCITX return over 5 years is better than : 28.54 vs. VTSNX (15.91).
GCITXVTSNXGCITX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD6.6824.535147%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.77B442B0%
Annual Yield % from dividends2.623.2980%
Returns for 1 year14.3610.92132%
Returns for 3 years5.93-5.86-101%
Returns for 5 years28.5415.91179%
Returns for 10 years69.0929.81232%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals